The Cancer Research Institute has published an updated global immuno-oncology landscape analysis highlighting a robust pipeline marked by rapid growth.
The study explores a potential non-invasive approach to identify tumor mutations.
Drs. Miriam Merad and Padmanee Sharma will be honored with the 2018 William B. Coley Award, while Dr. Boris Reizis will receive the Frederick W. Alt Award
The Cancer Research Institute announced that it will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
FNIH has selected CRI to be its source of landscape intelligence in immuno-oncology.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
More than 200 patients, caregivers, and advocates attended an Immunotherapy Patient Summit in San Diego on Saturday, June 29, 2019.
CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June 21 in New York City